David T. Dicker

Also affiliated with Cancer Research Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic”.

TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic

Oncotarget(2020)10.18632/oncotarget.27773

N/A

0DataRank · unranked

28 citations

Aakash Jhaveri, Jocelyn E. Ray, Lanlan Zhou, Avital Lev, Kerry S. Campbell +4 more

P53-independent restoration of p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.20.347401

N/A

0DataRank · unranked

3 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9

Neoplasia(2021)10.1016/j.neo.2021.01.004

N/A

0DataRank · unranked

28 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53

eLife(2021)10.7554/elife.70429

N/A

0DataRank · unranked

14 citations

David T. Dicker, John Santiago, Jennifer A. Sanders, Xiaobing Tian, Nagib Ahsan +4 more